Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/20/2025

Treatment of Cholinergic Intoxication

Protocol for Initial Treatment

  • The American Heart Association recommends atropine as the first-line medication for cholinergic intoxication, to be administered immediately in doses of 1-2 mg IV for adults (0.02 mg/kg for children), doubling the dose every 5 minutes until complete atropinization is achieved, always in conjunction with pralidoxime and benzodiazepines 1, 2
  • Remove contaminated clothing and perform copious irrigation with water and soap for dermal exposure 1
  • Use personal protective equipment (PPE) when handling contaminated patients to prevent secondary intoxication of healthcare professionals 1

Administration of Atropine

  • Initial dose for adults: 1-2 mg IV 1, 2
  • Initial dose for children: 0.02 mg/kg IV (minimum 0.1 mg, maximum single dose 0.5 mg) 1, 2
  • Double the dose every 5 minutes until atropinization is complete 1, 2
  • Never stop escalating the dose due to tachycardia - tachycardia is not a contraindication for continuing atropine administration 1
  • Cumulative doses can reach 10-20 mg in the first 2-3 hours, with some patients requiring up to 50 mg in 24 hours 2

Pralidoxime (2-PAM) Therapy

  • The American Heart Association recommends pralidoxime with evidence Class 2a, Level A 1
  • Pralidoxime should be administered early in conjunction with atropine, as it reverses the nicotinic effects that atropine cannot reverse 1
  • Initial IV dose for adults: 1-2 g, preferably as an infusion in 100 mL of saline solution over 15-30 minutes 1

Benzodiazepines

  • Administer benzodiazepines (diazepam or midazolam) to treat seizures and agitation 1, 2, 3
  • Benzodiazepines are essential for controlling CNS effects 3

Airway Management

  • Early endotracheal intubation is recommended for life-threatening intoxication 1
  • Observational data suggest better outcomes with early intubation in significant organophosphate poisoning 1
  • Avoid neuromuscular blockers metabolized by cholinesterase (succinylcholine and mivacurium) - they are not recommended for patients with organophosphate poisoning 1

Cardiovascular Considerations

  • Organophosphate poisoning causes a biphasic pattern of cardiac effects 4
  • Phase 1 (minutes): brief period of cardiac hyperstimulation with hypertension and sinus tachycardia due to nicotinic stimulation 4
  • Phase 2 (hours): severe cardiac depression manifested as bradycardia and hypotension due to parasympathetic hyperstimulation of muscarinic receptors 4
  • Alterations in ST-T segments may appear, as well as atrioventricular conduction disturbances 4, 3
  • Prolongation of the QTc interval on the ECG denotes a poor prognosis 4

Common Pitfalls and Precautions

  • Never underestimate the necessary doses - organophosphate poisoning often requires high total doses of atropine 2
  • The therapeutic goal is control of muscarinic symptoms, not normalization of heart rate 2
  • In children, relatively higher doses are necessary compared to standard pediatric resuscitation doses 1

Complications and Monitoring

  • Severe myonecrosis can result from excessive accumulation of acetylcholine causing calcium influx into skeletal muscle 1
  • Rhabdomyolysis with subsequent myoglobinuria can cause renal damage 1
  • Monitor creatine kinase and potassium levels 1
  • Treatment of rhabdomyolysis: adequate hydration, forced diuresis, and urine alkalization when urine turns reddish (due to myoglobin, not hemoglobin) 1
  • Monitor for late-onset muscle weakness, which can follow the initial cholinergic crisis up to 4 days after acute exposure 1
  • Restoration of normal enzyme activity can take up to 6 weeks in untreated patients 2
  • Maintain monitoring for at least 48-72 hours 1